ID
42199
Beschrijving
Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046
Link
https://clinicaltrials.gov/show/NCT01255046
Trefwoorden
Versies (3)
- 30-08-15 30-08-15 -
- 13-04-21 13-04-21 - Dr. rer. medic Philipp Neuhaus
- 18-11-21 18-11-21 -
Geüploaded op
13 april 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Alzheimer Disease NCT01255046
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Beschrijving
brain image (computed tomography (ct) scan or magnetic resonance imaging (mri) done within past 12 months prior to the study) and laboratory tests to exclude secondary dementia or non-alzheimer's dementia;
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0024485
- UMLS CUI [1,2]
- C0040405
- UMLS CUI [1,3]
- C0587081
Beschrijving
patient with significant clinically central nervous system illness other than ad (e.g. parkinson's disease, human immunodeficiency virus (hiv) induced dementia, hachinski ischaemic score (his) >4) or dementia complicated by other organic disease or delirium;
Datatype
boolean
Alias
- UMLS CUI [1]
- C0007682
Beschrijving
patient with a severe or uncontrolled diagnostic and statistical manual of mental disorders (dsm-iv) axis i disorder other than alzheimer's disease, including amnestic disorders, schizophrenia or schizoaffective disorder, bipolar disorder, current major depressive episode, psychosis, panic, or post-traumatic stress disorder;
Datatype
boolean
Alias
- UMLS CUI [1]
- C0004936
Beschrijving
patient suffering from cerebral disturbances following a stroke or a cerebral trauma (if the event occurred within the last 6 months);
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0038454
- UMLS CUI [1,2]
- C0234387
Beschrijving
patient with a history of hypersensitivity to study drugs;
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013182
Beschrijving
patient who has a history or evidence of a medical condition that would expose them to an undue risk of a significant adverse event or interfere with assessments of safety or efficacy during the course of the trial, including but not limited to hepatic, renal, respiratory, cardiovascular, endocrine (e.g., addison's disease), immune, neurologic, or hematologic disease as determined by the clinical judgment of the investigator;
Datatype
boolean
Alias
- UMLS CUI [1]
- C3843040
Beschrijving
participation in any research study within the last 30 days;
Datatype
boolean
Alias
- UMLS CUI [1]
- C0008976
Beschrijving
patient with significant alcohol or drug abuse as judged by the investigator.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0237123
Similar models
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
CL386174 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
C0677408 (UMLS CUI [2])
C0040405 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
C0234387 (UMLS CUI [1,2])